The bipartisan CLAIM Act would protect insurers, brokers, and agents from federal penalties solely for serving state legal cannabis businesses. The proposal could encourage greater carrier participation while leaving underwriting decisions, state regulation, pricing, exclusions, and coverage terms in the hands of insurers.

California expanded cannabis recalls after regulators suspended a Lake County cultivation operation tied to suspected pesticide exposure and a worker death investigation. The case highlights serious operator risk around pesticide controls, worker safety, track and trace accuracy, product recalls, environmental compliance, and insurance claims.

A Pennsylvania performance audit found weaknesses in medical cannabis inspections, complaint handling, enforcement documentation, and corrective action oversight. The findings could lead to more standardized regulatory reviews and make strong operator records, SOPs, training, and internal compliance systems increasingly important.

An Ohio dispensary voluntarily closed after two customers reported serious adverse health effects involving cannabis vapes. Follow up testing found no harmful contaminants, but the investigation shows how quickly product complaints can trigger inventory holds, operational disruption, recall procedures, and claims exposure.

Houston misdemeanor cannabis possession arrests have risen nearly 1,200 percent, from an average of about 35 per year from 2021 through 2023 to roughly 440 annually during the current mayoral administration. The surge comes as voters prepare to decide whether low level cannabis possession should become HPD's lowest enforcement priority.

Federal courts continue scrutinizing cannabis contracts when enforcement would implicate activity prohibited by federal law. Recent cases show why operators, investors, lenders, and landlords need to consider venue, remedies, deal structure, and federal enforceability before disputes occur.

French CBD trade groups are awaiting a key Council of State ruling after regulators tightened enforcement against CBD foods and supplements. The decision could reshape product access, imports, inventory, supplier relationships, and compliance planning across one of Europe's most important CBD markets.

SAM Action has contributed approximately $3.2 million to the campaign supporting Massachusetts Question 8, which would eliminate regulated adult use cannabis sales. The November vote creates significant uncertainty around licenses, jobs, tax revenue, property, investment, and operator survival in one of the country's mature cannabis markets.

Missouri regulators recalled cannabis products from GF Extraction Lab LLC after finding cannabinoids produced through chemical modification, conversion, or synthetic derivation. The action highlights growing pressure around manufacturing controls, ingredient traceability, testing, inventory management, recalls, and retailer compliance.

An explosion at a licensed Oklahoma medical cannabis processor killed two people and damaged numerous neighboring businesses, raising serious questions about extraction safety, fire code compliance, landlord exposure, and insurance. The cause remains under investigation, but the incident shows why a cannabis license must be supported by facility controls that match the actual processing operation.